Abstract
Cytochromes P450 (P450s or CYPs) constitute a superfamily of heme-containing monooxygenases and have been shown to play a major role in both xenobiotic and endogenous metabolism. Thanks to the Human Genome Project, the current list of human CYPs should be exhaustive and so far 57 P450 encoding genes have been identified. To date, fif-teen of them, generally called “orphans” cytochromes P450, which were mainly identified by homology research between the sequences of known P450s and genomic sequences or ESTs (Expressed Sequence Tags) databases, are not fully char-acterized. However, tissue distribution, catalytic properties and physiological functions of these “novel P450s” are being analysed and partial results are already available for some of them, including CYP2 (CYP2A13, CYP2R1, CYP2S1, CYP2U1 and CYP2W1), CYP3 (CYP3A43) and CYP4 (CYP4A22, CYP4F12, CYP4F22, CYP4V2, CYP4X1, CYP4Z1) family members. In this review, we present some of the current data characterizing these P450s and discuss their potential involvement in xenobiotic toxicity and carcinogenesis, as well as their physiological relevance in pathology susceptibility.
Keywords: Cytochromes P450, Human Genome Project, xenobiotics, pharmacogenetics
Current Genomics
Title: What Have We Learned from the Novel Human Cytochromes P450 Hidden in the Databases?
Volume: 7 Issue: 5
Author(s): Christelle Cauffiez
Affiliation:
Keywords: Cytochromes P450, Human Genome Project, xenobiotics, pharmacogenetics
Abstract: Cytochromes P450 (P450s or CYPs) constitute a superfamily of heme-containing monooxygenases and have been shown to play a major role in both xenobiotic and endogenous metabolism. Thanks to the Human Genome Project, the current list of human CYPs should be exhaustive and so far 57 P450 encoding genes have been identified. To date, fif-teen of them, generally called “orphans” cytochromes P450, which were mainly identified by homology research between the sequences of known P450s and genomic sequences or ESTs (Expressed Sequence Tags) databases, are not fully char-acterized. However, tissue distribution, catalytic properties and physiological functions of these “novel P450s” are being analysed and partial results are already available for some of them, including CYP2 (CYP2A13, CYP2R1, CYP2S1, CYP2U1 and CYP2W1), CYP3 (CYP3A43) and CYP4 (CYP4A22, CYP4F12, CYP4F22, CYP4V2, CYP4X1, CYP4Z1) family members. In this review, we present some of the current data characterizing these P450s and discuss their potential involvement in xenobiotic toxicity and carcinogenesis, as well as their physiological relevance in pathology susceptibility.
Export Options
About this article
Cite this article as:
Cauffiez Christelle, What Have We Learned from the Novel Human Cytochromes P450 Hidden in the Databases?, Current Genomics 2006; 7 (5) . https://dx.doi.org/10.2174/138920206778604359
DOI https://dx.doi.org/10.2174/138920206778604359 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hydrogen Sulphide and Pain
Inflammation & Allergy - Drug Targets (Discontinued) Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives
Current Topics in Medicinal Chemistry A Role of Immunotherapy in Metastatic Malignant Melanoma
Central Nervous System Agents in Medicinal Chemistry Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs
Current Pharmacogenomics and Personalized Medicine A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
Cardiovascular & Hematological Disorders-Drug Targets Nummular Eczema: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Nutritional Targeting of Cyclooxygenase-2 for Colon Cancer Prevention
Inflammation & Allergy - Drug Targets (Discontinued) Lanreotide and its Potential Applications in Polycystic Kidney and Liver Diseases
Current Topics in Medicinal Chemistry Biomarkers, Critical Disease Pathways, Drug Targets, and Alternative Medicine in Male Breast Cancer
Current Drug Targets Development of Pin1 Inhibitors and their Potential as Therapeutic Agents
Current Medicinal Chemistry Connection between JAK/STAT and PPARγ Signaling During the Progression of Multiple Sclerosis: Insights into the Modulation of T-Cells and Immune Responses in the Brain
Current Molecular Pharmacology Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Targeting Tumor-Related Immunosuppression for Cancer Immunotherapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Punicic Acid Inhibits Glioblastoma Migration and Proliferation via the PI3K/AKT1/mTOR Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Cytotoxic Properties of Clofibrate and other Peroxisome Proliferators: Relevance to Cancer Progression
Current Medicinal Chemistry Lipoprotein (a) Evolution: Possible Benefits and Harm. Genetic and Non-Genetic Factors Influencing its Plasma Levels
Current Medicinal Chemistry Protein Aggregation and Self Assembly in Health and Disease
Current Proteomics Machine Learning-Based Virtual Screening Strategy RevealsSome Natural Compounds as Potential PAK4 Inhibitors in Triple Negative Breast Cancer
Current Proteomics